MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells
暂无分享,去创建一个
Jia-yin Yao | Jun Nie | Fang Huang | Tao‐Le Liu | Qing Lv | Lei Zhang | Tian Ma | Wen Wang | Xiang Peng | Jun Zhao | Dechen Lin | Gang Jin | Jinhe Gao | J. Yao
[1] Minoru Kanehisa,et al. KEGG: integrating viruses and cellular organisms , 2020, Nucleic Acids Res..
[2] R. Deberardinis,et al. Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small cell lung cancer. , 2020, The Journal of clinical investigation.
[3] Minoru Kanehisa,et al. Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.
[4] D. Calvisi,et al. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis , 2017, Hepatology.
[5] R. Abraham,et al. Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase. , 2017, Cell reports.
[6] R. Chen,et al. TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway , 2017, Oncogenesis.
[7] X. Chen,et al. Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways , 2017, Oncogene.
[8] L. Yao,et al. NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation. , 2017, Biochemical and biophysical research communications.
[9] Matthew G. Vander Heiden,et al. Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.
[10] R. Schwabe,et al. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. , 2017, Annual review of pathology.
[11] J. Asara,et al. The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis. , 2016, Molecular cell.
[12] E. Bugianesi,et al. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. , 2016, Annual review of medicine.
[13] N. Pavlova,et al. The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.
[14] A. Satyanarayana,et al. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] J. Revuelta,et al. Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases , 2015, Nature Communications.
[16] Hong Zhang,et al. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice. , 2015, Gastroenterology.
[17] Hanhua Cheng,et al. MYBL2 guides autophagy suppressor VDAC2 in the developing ovary to inhibit autophagy through a complex of VDAC2-BECN1-BCL2L1 in mammals , 2015, Autophagy.
[18] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[19] Rugang Zhang,et al. Nucleotide metabolism, oncogene-induced senescence and cancer. , 2015, Cancer letters.
[20] J. Rappsilber,et al. Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control , 2015, Nature Communications.
[21] Xiang Zhou,et al. The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress , 2014, eLife.
[22] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[23] Timothy E. Reddy,et al. Distinct properties of cell-type-specific and shared transcription factor binding sites. , 2013, Molecular cell.
[24] M. Gorospe,et al. Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB , 2013, PLoS genetics.
[25] D. DiMaio,et al. B-Myb, cancer, senescence, and microRNAs. , 2011, Cancer research.
[26] D. Calvisi,et al. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype. , 2011, Journal of hepatology.
[27] D. Calvisi,et al. Activation of v‐Myb avian myeloblastosis viral oncogene homolog‐like2 (MYBL2)‐LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 , 2011, Hepatology.
[28] J. Steitz,et al. miR-29 and miR-30 regulate B-Myb expression during cellular senescence , 2010, Proceedings of the National Academy of Sciences.
[29] J. Blenis,et al. Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.
[30] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[31] J. Inazawa,et al. Activation of B‐Myb by E2F1 in hepatocellular carcinoma , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.
[32] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[33] L. Bernd,et al. Prognostic significance of drug-regulated genes in high-grade osteosarcoma , 2007, Modern Pathology.
[34] Jun O. Liu,et al. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. , 2006, Journal of medicinal chemistry.
[35] Y. Rao,et al. De Novo GMP Synthesis Is Required for Axon Guidance in Drosophila , 2006, Genetics.
[36] R. Yazdanparast,et al. 3-Hydrogenkwadaphnin targets inosine 5'-monophosphate dehydrogenase and triggers post-G1 arrest apoptosis in human leukemia cell lines. , 2005, The international journal of biochemistry & cell biology.
[37] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[38] A. Allison,et al. Mycophenolate mofetil and its mechanisms of action. , 2000, Immunopharmacology.
[39] M. Grusch,et al. Consequences of IMP Dehydrogenase Inhibition, and its Relationship to Cancer and Apoptosis , 1999, Current Medicinal Chemistry.
[40] J. Mangum,et al. Inosine monophosphate dehydrogenase and myeloid cell maturation. , 1987, Blood.
[41] R. Jackson,et al. Partial purification, properties and regulation of inosine 5'phosphate dehydrogenase in normal and malignant rat tissues. , 1977, The Biochemical journal.
[42] R. Jackson,et al. IMP dehydrogenase, an enzyme linked with proliferation and malignancy , 1975, Nature.
[43] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[44] Sonja B. Braun-Sand,et al. Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics. , 2010, Future medicinal chemistry.
[45] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[46] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[47] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.
[48] M. Wintzerith,et al. [Comparative study of free uridylic nucleotides in the normal liver, the regenerating liver and in the Zajdela hepatoma]. , 1962, Comptes rendus des seances de la Societe de biologie et de ses filiales.